"What is more valuable a ... a therapeutic that will work 90% of the time against This virus and other ones to come in the future? Pretty easy to answer. Imagine how much a company like Pfizer would be making right now if they owned our drug.
FDA/Barda...is not giving to priority to a "one trick poney"...the big bucks are and will be going out to Therapeutic Compounds/Drugs that can be developed to hit and Kill MULTIPLE VIRUSES...
Leo noted in PR that (and that should be a hint regarding FDA/Barda interest) that further studies are being conducted for Pan-coronaviruses ...
follow the money...
IMO...it will lead to funding announcement (timing?) for Brilacidin R&D Funding and utilization.
News 
Market Data 
Discover 
